New Drugs to Be Developed Against Microbial Diseases Through BARÜ Project
15 Ağustos 2025
Through a project supported by TÜSEB, Bartın University (BARÜ) will develop new drugs against bacterial microbial diseases using various approaches.
A project led by Buket Yıldırım, a master’s student in the Department of Molecular Biology and Genetics at the Graduate School of Bartın University (BARÜ), has been awarded funding under the A Group Emergency R&D Project Support Program of the Presidency of Turkish Institutes of Health (TÜSEB).
Titled “Investigation of the In Vitro, In Silico, and Transcription-Based Antimicrobial Effects of DHFR-Targeted Pyrimidine Derivatives,” the project has been developed under the supervision of Assoc. Prof. Dr. Dursun Kısa from the Department of Molecular Biology and Genetics and Prof. Dr. Ayşegül Gümüş from the Department of Biotechnology. The study aims to eliminate the vital functions of bacteria that cause infections.
Within the scope of the project, the research team will synthesize four candidate compounds designed with pharmacological properties to combat microbial infections. The drug potential of these synthesized compounds will be evaluated through various scientific analysis methods.
BARÜ Rector Prof. Dr. Ahmet Akkaya congratulated master’s student Buket Yıldırım and the project team for their innovative work supported by TÜSEB in the field of human health and wished them continued success.
BARÜ Communications Coordination Office
BARÜ Communications Coordination Office
Fotoğraflar
Haberler
